Late-stage results set up Cytokinetics heart drug to compete with Bristol

13 May 2024, 2:44 am

Late-stage results of Cytokinetics’ drug for a rare heart disease suggest it can compete with a similar treatment sold by Bristol Myers Squibb, and can also be dosed more conveniently.... Read More »

More Topics from "News"

• Overcast weekend followed by big warm-up next week across Southern New England
• UK builds world’s smallest light detector to shrink quantum computers
• West Country's biggest new forest in a generation to be created near Bristol
• Boeing opens new UK defence facility at headquarters in Bristol
• Bristol’s ‘zip-zip man’ Harry Randall ‘should be England scrum half’
• Bristol named one of the UK's most walkable cities
• Cost of living: Bristol bands struggling as small venues close
• Palestinian sent to Bristol after being told by Israeli police to ‘leave or spend 10 years in prison’
• Why England’s richest club Bristol are tightening belt